| ICIs | Immune checkpoint inhibitors |
| PD-1 | Programmed cell death 1 |
| CTLA-4 | Cytotoxic T lymphocyte-associated antigen-4 |
| Trp | Tryptophan |
| NAD+ | Nicotinamide adenine dinucleotide |
| IDO | Indoleamine 2,3-dioxygenase |
| 13AA | Indole-3-acetaldehyde |
| HCC | Hepatocellular carcinoma |
| ROS | Reactive oxygen species |
| BH4 | Tetrahydrobiopterin |
| IFNγ | Interferon γ |
| USP14 | Ubiquitin-specific protease-14 |
| Treg | Regulatory T cells |
| ORR | Overall response rate |
| MAPK | Mitogen activated protein kinases |
| NSCLC | Non-small cell lung cancer |
| TNBC | Triple negative breast cancer |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| GLS | Glutaminase |
| TME | Tumor microenvironment |
| αKG | α-ketoglutarate |